Literature DB >> 27725907

miR-489 acts as a tumor suppressor in human gastric cancer by targeting PROX1.

Bin Zhang1, Sheqing Ji1, Fei Ma1, Qi Ma1, Xianzhi Lu1, Xiaobing Chen1.   

Abstract

Dysregulation of microRNAs (miRNAs) are linked to tumorigenesis and tumor progression. In this study, we examined the expression of miR-489 in gastric cancer tissues and cells. Loss- and gain-of-function experiments were done to determine the roles of miR-489 in gastric cancer cell proliferation and invasion. Bioinformatic prediction, luciferase reporter assays, and Western blot analysis were employed to identify the target gene(s) of miR-489. We found that miR-489 was significantly (P < 0.05) downregulated in human gastric cancer tissues and cell lines, compared to their non-malignant counterparts. Enforced expression of miR-489 significantly suppressed gastric cancer cell proliferation and invasion, while miR-489 knockdown enhanced the aggressive behaviors of gastric cancer cells. Prospero homeobox 1 (PROX1) was identified to be a direct target of miR-489. A significant negative correlation was seen between miR-489 and PROX1 protein expression in gastric cancer tissues (r = -0.462, P = 0.023). Silencing of PROX1 phenocopied the suppressive effects of miR-489 in gastric cancer cells. Rescue experiments demonstrated that overexpression of a miR-489-resistant form of PROX1 significantly prevented the reduction in cell proliferation and invasion induced by miR-489 overexpression. In vivo studies confirmed that miR-489 overexpression retarded the growth of xenograft tumors, which was accompanied by reduced PROX1 expression. Overall, these data provide evidence for the suppressive activity of miR-489 in gastric cancer, which is ascribed to targeting of PROX1. The miR-489/PROX1 axis may represent a potential therapeutic target for this disease.

Entities:  

Keywords:  Gastric cancer; invasiveness; microRNA; target genes; tumorigenesis

Year:  2016        PMID: 27725907      PMCID: PMC5043111     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  23 in total

Review 1.  An overview of real-time quantitative PCR: applications to quantify cytokine gene expression.

Authors:  A Giulietti; L Overbergh; D Valckx; B Decallonne; R Bouillon; C Mathieu
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  The perfect storm of tiny RNAs.

Authors:  Gary Ruvkun
Journal:  Nat Med       Date:  2008-10       Impact factor: 53.440

Review 3.  Towards a molecular understanding of microRNA-mediated gene silencing.

Authors:  Stefanie Jonas; Elisa Izaurralde
Journal:  Nat Rev Genet       Date:  2015-06-16       Impact factor: 53.242

4.  PROX1 is involved in progression of rectal neuroendocrine tumors, NETs.

Authors:  Juha Jernman; Pauliina Kallio; Jaana Hagström; Matti J Välimäki; Hannu Haapasalo; Kari Alitalo; Johanna Arola; Caj Haglund
Journal:  Virchows Arch       Date:  2015-06-11       Impact factor: 4.064

5.  PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.

Authors:  Y Liu; X Ye; J-B Zhang; H Ouyang; Z Shen; Y Wu; W Wang; J Wu; S Tao; X Yang; K Qiao; J Zhang; J Liu; Q Fu; Y Xie
Journal:  Oncogene       Date:  2015-02-16       Impact factor: 9.867

6.  MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression.

Authors:  L Scapoli; A Palmieri; L Lo Muzio; F Pezzetti; C Rubini; A Girardi; F Farinella; M Mazzotta; F Carinci
Journal:  Int J Immunopathol Pharmacol       Date:  2010 Oct-Dec       Impact factor: 3.219

7.  miR-543 promotes gastric cancer cell proliferation by targeting SIRT1.

Authors:  Juan Li; Guoying Dong; Bo Wang; Wei Gao; Qing Yang
Journal:  Biochem Biophys Res Commun       Date:  2015-11-22       Impact factor: 3.575

8.  GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion.

Authors:  Peng Chai; Jingzhong Tian; Deyin Zhao; Hongyan Zhang; Jian Cui; Keshuo Ding; Bin Liu
Journal:  Biochem Biophys Res Commun       Date:  2016-01-30       Impact factor: 3.575

9.  miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC).

Authors:  N Kikkawa; T Hanazawa; L Fujimura; N Nohata; H Suzuki; H Chazono; D Sakurai; S Horiguchi; Y Okamoto; N Seki
Journal:  Br J Cancer       Date:  2010-08-10       Impact factor: 7.640

10.  A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth.

Authors:  Yogin Patel; Nirav Shah; Ji Shin Lee; Eleni Markoutsa; Chunfa Jie; Shou Liu; Rachel Botbyl; David Reisman; Peisheng Xu; Hexin Chen
Journal:  Oncotarget       Date:  2016-04-05
View more
  18 in total

1.  miR-489 suppresses multiple myeloma cells growth through inhibition of LDHA-mediated aerobic glycolysis.

Authors:  Han Wu; Xiuhong Wang; Tingting Wu; Su Yang
Journal:  Genes Genomics       Date:  2019-12-23       Impact factor: 1.839

2.  Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer.

Authors:  Mithil Soni; Yogin Patel; Eleni Markoutsa; Chunfa Jie; Shou Liu; Peisheng Xu; Hexin Chen
Journal:  Mol Cancer Res       Date:  2018-05-21       Impact factor: 5.852

3.  Circ_0007534 Silencing Inhibits the Proliferation, Migration and Invasion and Induces the Apoptosis of Glioma Cells Partly Through Down-Regulating PROX1 Via Elevating miR-22-3p Level.

Authors:  Yong Zheng; Yan Wang; Rongkang Mai; Liang Liu; Zifeng Zhu; Yiyao Cao
Journal:  Cell Mol Neurobiol       Date:  2021-09-18       Impact factor: 4.231

Review 4.  Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential.

Authors:  Dharambir Kashyap; Hardeep Singh Tuli; Vivek Kumar Garg; Neelam Goel; Anupam Bishayee
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

5.  Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.

Authors:  Jing Wang; Xiaofeng Xue; Han Hong; Mingde Qin; Jin Zhou; Qing Sun; Hansi Liang; Ling Gao
Journal:  Oncotarget       Date:  2017-01-03

6.  Upregulated circ RNA hsa_circ_0000337 promotes cell proliferation, migration, and invasion of esophageal squamous cell carcinoma.

Authors:  Huan Song; Dian Xu; Peiyi Shi; Biyu He; Zhongqi Li; Ye Ji; Charles Kwaku Agbeko; Jianming Wang
Journal:  Cancer Manag Res       Date:  2019-03-04       Impact factor: 3.989

7.  Identification of microRNAs associated with the aggressiveness of prolactin pituitary tumors using bioinformatic analysis.

Authors:  Zihao Wang; Lu Gao; Xiaopeng Guo; Chenzhe Feng; Kan Deng; Wei Lian; Bing Xing
Journal:  Oncol Rep       Date:  2019-05-28       Impact factor: 3.906

8.  Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP.

Authors:  Xuedong Wang; Xinguo Wang; Juan Gu; Ming Zhou; Zhimin He; Xinhui Wang; Soldano Ferrone
Journal:  Oncotarget       Date:  2017-12-06

9.  High PROX1 expression in gastric cancer predicts better survival.

Authors:  Alli Laitinen; Camilla Böckelman; Jaana Hagström; Arto Kokkola; Pauliina Kallio; Caj Haglund
Journal:  PLoS One       Date:  2017-08-30       Impact factor: 3.240

10.  The association of transcription factor Prox1 with the proliferation, migration, and invasion of lung cancer.

Authors:  Xinxin Hao; Wenting Luo; Xueshan Qiu
Journal:  Open Life Sci       Date:  2021-06-19       Impact factor: 0.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.